Download PDF
Horm Metab Res 2011; 43(3): e1
DOI: 10.1055/s-0030-1268483
Erratum

© Georg Thieme Verlag KG Stuttgart · New York

Combination Therapy with Nateglinide and Telmisartan Ameliorates Insulin Resistance in Zucker Fatty Rats by Suppressing Advanced Glycation End Product Receptor Axis

K. Miura1 , Y. Kitahara1 , T. Kajioka1 , M. Takeuchi2 , S. Yamagishi3
  • 1Exploratory Research Laboratories, Ajinomoto Pharmaceuticals Co. Ltd., Kawasaki, Japan
  • 2Department of Life Pharmacy, Faculty of Pharmaceutical Sciences, Hokuriku University, Kanazawa, Japan
  • 3Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, Kurume University School of Medicine, Kurume, Japan
Further Information

Publication History

Publication Date:
16 November 2010 (online)

Also available at
    Permissions and Reprints

Correction to:

Combination Therapy with Nateglinide and Telmisartan Ameliorates Insulin Resistance in Zucker Fatty Rats by Suppressing Advanced Glycation End Product Receptor AxisHorm Metab Res 2011; 43(03): 226-228
DOI: 10.1055/s-0030-1267227

Combination Therapy with Nateglinide and Telmisartan Ameliorates Insulin Resistance in Zucker Fatty Rats by Suppressing Advanced Glycation End Product Receptor Axis

K. Miura, Y. Kitahara, T. Kajioka, M. Takeuchi, S. Yamagishi

Hormone and Metabolic Research 2010; advance online publication: DOI: 10.1055/s-0030-1267227

One of the authors' name is misspelt. The correct name is M. Takeuchi.

      >